Skip to content Skip to footer
Identifying Drug Repurposing Opportunities with AI Literature Review

ISPOR 2026: Identifying Drug Repurposing Opportunities with AI Literature Review

AI-Assisted Drug Repurposing What if the next breakthrough treatment is already available today, hidden within existing drugs and waiting to be discovered? This question drives the growing field of AI-assisted drug repurposing, a smart and cost-effective strategy that looks for new therapeutic uses for approved medications. Unlike traditional drug development, which can cost billions and…

Read More

AI Implementation

The Biggest Challenges to Implementing AI in Life Sciences

The promise of Artificial Intelligence (AI) in life sciences is undeniable—offering advancements in drug discovery, clinical research, and evidence generation. Yet, many organizations still struggle to implement AI effectively. To better understand these challenges, CapeStart conducted a survey of 104 life science professionals, asking them:  What are the top three barriers to success for your…

Read More

AI’s Biggest Wins

AI’s Biggest Wins: Three Core Business Areas Benefiting the Most

Across industries, businesses are turning to AI to address pressing challenges, drive innovation, and improve efficiency. According to CapeStart’s Life Science AI Research Report, organizations are increasingly identifying specific areas where AI can deliver the greatest value. By focusing on key business functions, companies aim to unlock new opportunities, streamline operations, and enhance their impact…

Read More